Hong Kong Stock Movement | WuXi Biologics (02269.HK) rises over 4%, plans to acquire Chengsheng Pharmaceuticals process development and production base in Hangzhou.

Zhitong Finance APP learned that WuXi Biologics (02269.HK) rose more than 4%. As of press time, it is up 4.25%, trading at HKD 43.14, with a transaction volume of HKD 368 million.